Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1Phase 1/2 1

Status

Unknown 2Completed 1

Sponsor Class

INDUSTRY 2OTHER 1

Study Type

Interventional 3

Sponsor

Cancer Type

Thoracic 3

Conditions

Carcinoma, Non-Small-Cell Lung 31Lung Neoplasms 9Small Cell Lung Carcinoma 4Respiratory Tract Diseases 3NSCLC 3Lung Diseases 3Thoracic Neoplasms 2Extensive Stage Small Cell Lung Cancer 2Carcinoma, Bronchogenic 2Bronchial Neoplasms 2Small Cell Lung Cancer Extensive Stage 1Respiratory Tract Neoplasms 1Radiation Pneumonitis 1Pleural Effusion, Malignant 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1PD-L1 Positive Non-small Cell Lung Cancer 1Non-squamous Non-small-cell Lung Cancer 1Non-squamous Non-small Cell Lung Cancer 1Non Squamous Non Small Cell Lung Cancer 1Neoplasms by Site 1Neoplasms 1Multiple Primary Lung Cancer 1Esophageal Neoplasms 1CRC 1Brain Neoplasms 1Advanced NSCLC 1Adenocarcinoma of Lung 1

Interventions

Carboplatin 9Pemetrexed 6Erlotinib Hydrochloride 5pembrolizumab 3osimertinib 3durvalumab 3camrelizumab 3Gemcitabine 3Gefitinib 3Cisplatin 3selpercatinib 2pralsetinib 2apatinib 2Radiosurgery 2taletrectinib 1sotorasib 1sintilimab 1repotrectinib 1patritumab 1necitumumab 1ficlatuzumab 1exemestane 1entinostat 1cobimetinib 1ceralasertib 1alectinib 1Vinorelbine 1Tyrosine Kinase Inhibitors 1Telescopes 1Radiotherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Respiratory Tract Diseases × camrelizumab × Thoracic × Clear all
NCT03085069 2023-02-16

A Study to Evaluate SHR-1210 in Patients With Advanced or Metastatic NSCLC

Jiangsu HengRui Medicine Co., Ltd.

Phase 2 Unknown
146 enrolled
Thoracic

Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, Lung Diseases, Lung Neoplasms, Respiratory Tract Diseases

NCT03134872 2020-06-09

A Study of SHR-1210 in Combination With Pemetrexed and Carboplatin in Subjects With Non-squamous NSCLC

Jiangsu HengRui Medicine Co., Ltd.

Phase 3 Completed
419 enrolled
Thoracic

Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, Lung Diseases, Lung Neoplasms, Neoplasms by Site, Respiratory Tract Diseases, Respiratory Tract Neoplasms, Thoracic Neoplasms

NCT04133337 2019-10-21

Apatinib Combined With SHR-1210 Injection in the Treatment of Patients With Removable IB-IIIA NSCLC

Sichuan Cancer Hospital and Research Institute

Phase 1/2 Unknown
20 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Diseases, Neoplasms, Respiratory Tract Diseases, Thoracic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡